Bioluminescence Ventures

Our Senior Partner Campbell Murray enjoyed a thoughtful discussion on syndicate building with industry leaders this week at the @LongwoodLeaders event in Boston.

🗞️ BLV and its portfolio companies were busy making news in Q3! Here are some highlights from @ReCodeTx and @Cerevance, as well as an addition to our own leadership team. Keep up to date on all our news: bioluminescence.com/press/

We are thrilled to announce the newest addition to our team – please join us in welcoming @Campbel83265527 as our new Senior Partner! With an impressive background in biotech investing and operations, he will undoubtedly help drive our firm to new heights. rb.gy/nsv1l2

We’re excited to welcome Geney Park to Bioluminescence! Her background in bioengineering and clinical-stage cell therapy, and wide skillset will be invaluable as we continue to support and invest in transformative platform technology companies that aim to improve humanity.

What an insightful discussion! Thanks to everyone who attended yesterday’s #BIO2024 panel, as well as moderator @gwendolynawu and fellow panelists @AymanAlabdallah, Nate Chang, and @Car0lyn_Ng

How can #biopharma companies reduce time-to-market without compromising quality? Incorporate a patient-first approach into scientific, target-first conversations, advises BLV partner Andy Seid. See what other insights he has shared with Pharma's Almanac: pharmasalmanac.com/articles/what-…

What are some of the unsung tech sectors? @KoukiHarasaki shares his insights with the @WSJ harmonixfund.com/the-unsung-tec…

What better way to start the year than with celebrations and collaborations? It was a busy #JPM24, and not just for business dealings. We enjoyed connecting with colleagues old and new. Here's to a successful 2024! 🥂

Great news for the New Year: Bioluminescence Ventures announces four distinguished partners whose fusion of science & business acumen will help steer our commitment to transformative #biotech investments businesswire.com/news/home/2024…

Exciting news: Bioluminescence Ventures emerges from stealth with $477M AUM. Led by experienced investor and scientist @KoukiHarasaki, the firm is on a mission to support transformative companies developing therapies for unmet medical needs. Learn more: shorturl.at/bjpU4

From TALENs to CRISPR & Beyond: What's on the horizon for #geneediting? Join @KoukiHarasaki tomorrow at 9 am, as he leads a #BIO2023 panel, including Amy Simon of @BeamTx, Michael Holmes of @TesseraTx, Jeremy Duffield of @PrimeMedicine & Emile Nuwaysir of @EnsomaBio.

What are emerging approaches to drug discovery in #oncology? Join @KoukiHarasaki tomorrow at 1:45 pm, as he leads a #BIO2023 panel including Don Kirkpatrick of @InterlineTx, @dennis_zaller of @rome_tx, Li Peng of @Palleon_Pharma & Christian Dimaano of Kinnate Biopharma.

Are we ushering in a Golden Age of RNA? Join @KoukiHarasaki tomorrow at 11 am, as he leads a #BIO2023 panel of experts, including @afzelius_lovisa of @FlagshipPioneer, @raphaeljlt of @AtomicAICo, Zelanna Goldberg of @Replicate_Bio, and @angelemaki of @ReCodeTx.

Heading to Boston for #BIO2023? Be sure to add the following panels to your agenda and contact us to connect! bit.ly/3pvx0Wt

Bioluminescence founder @KoukiHarasaki will be bringing his insights to #BIO2023 as he leads several expert panels on emerging therapies in #RNA, #oncology and #geneediting. Stay tuned for details, or get a sneak peek here: bit.ly/3pvx0Wt

Congratulations to the @EnsomaBio team on the announcement of their $50M Series B Extension financing today. Bioluminescence Ventures is proud to have co-led this round with Kite Pharma/Gilead Sciences. Read more here: bwnews.pr/3Icwt1R

Congratulations to the @NidoBiosciences team on their launch from stealth yesterday. Bioluminescence Ventures is proud to have led their recent Series B financing. See their news here: bwnews.pr/41BVpH6

We're looking forward to hearing about #biotech breakthroughs and industry innovations at #BIO2023! If you'd like to connect or learn more about Bioluminescence Ventures, please reach out to us at info@bioluminescence.com.